<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2D96BCF4-9D78-4FF3-A708-B1451AEEA83F"><gtr:id>2D96BCF4-9D78-4FF3-A708-B1451AEEA83F</gtr:id><gtr:name>WorldSkills Europe</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C00F5E54-1020-4E0F-99D1-BEFC4CA1323C"><gtr:id>C00F5E54-1020-4E0F-99D1-BEFC4CA1323C</gtr:id><gtr:name>Synta Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/06E00C8B-5239-4BA3-84A0-477D5A697019"><gtr:id>06E00C8B-5239-4BA3-84A0-477D5A697019</gtr:id><gtr:name>University of Naples</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D96BCF4-9D78-4FF3-A708-B1451AEEA83F"><gtr:id>2D96BCF4-9D78-4FF3-A708-B1451AEEA83F</gtr:id><gtr:name>WorldSkills Europe</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C00F5E54-1020-4E0F-99D1-BEFC4CA1323C"><gtr:id>C00F5E54-1020-4E0F-99D1-BEFC4CA1323C</gtr:id><gtr:name>Synta Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/06E00C8B-5239-4BA3-84A0-477D5A697019"><gtr:id>06E00C8B-5239-4BA3-84A0-477D5A697019</gtr:id><gtr:name>University of Naples</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1789D1AD-2F4A-4850-9D32-46BBE9E8FEF9"><gtr:id>1789D1AD-2F4A-4850-9D32-46BBE9E8FEF9</gtr:id><gtr:firstName>L. Miguel</gtr:firstName><gtr:surname>Martins</gtr:surname><gtr:orcidId>0000-0002-3019-4809</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U132674518"><gtr:id>B5846C44-FED2-4D0F-806D-B3FA5191AE57</gtr:id><gtr:title>Mitochondria and Cell Death Regulation following toxic injury</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U132674518</gtr:grantReference><gtr:abstractText>Tissue homeostasis relies on the tightly controlled removal of excessive cells normally through a form of cell suicide termed apoptosis. Whereas an aberrant resistance to apoptosis participates in the development of cancer, excessive cell death, contributes to neurodegenerative diseases like Parkinson?s disease. Mitochondria, essential cellular components responsible for converting the energy in food into fuel for the cells, have been recently found to be key regulators of cell death. Our research focuses on understanding how mitochondria regulate cell death and how this process can be impaired in cancer cells. Additionally, given that we have established a link between specific mitochondrial proteins and Parkinson?s disease, we are interested in determining how defects in these proteins contribute to this neurodegenerative disease. Parkinson?s disease occurs when certain nerve cells, or neurons, in an area of the brain known as the substantia nigra become impaired or die. These neurons normally produce a chemical messenger called dopamine, which is responsible for transmitting signals that ensure smooth, purposeful muscle activity. The loss of dopamine causes the nerve cells to fire out of control, preventing patients from directing or controlling their movements in a normal manner. Some toxic substances in the environment, as well as some illicit drugs can affect mitochondrial function giving rise to parkinsonism in some individuals. We believe that our research might provide links between susceptibility to toxic agents that contribute to Parkinson?s disease and mutations in some of the proteins we are characterizing.</gtr:abstractText><gtr:technicalSummary>The focus of our research is to better understand the control of cellular death processes in normal cells and in pathological states with alterations of these processes. Our aim is to achieve a better understanding of the regulatory mechanisms controlling cell death. Understanding the basic biology of these processes can provide insights that are aimed to deliver field-changing mechanistic insights into toxicology and disease.
Part of our research addresses the function of mitochondrial proteins such as the protease HtrA2 and PINK1 and their role in stress responses. Mutations in HtrA2 and PINK1 are linked to Parkinson?s disease and we identified a mitochondrial stress-sensing pathway that involves the interaction between these two proteins.
Our work focuses on mitochondrial signaling pathways of toxicity associated with neurodegenerative diseases. The aim of this work is to target these pathways to improve neuronal health in models of Parkinson?s disease and other diseases related to mitochondrial dysfunction. We use the fruit fly as a model system to study organs and tissues with high energetic demand, such as the brain and muscles, that are susceptible to toxic insults.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>7731365</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Published on Jun 23, 2016
http://dx.doi.org/10.1038/cddis.2016.173
Celardo et al. &amp;quot;Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease&amp;quot;</gtr:description><gtr:id>C5254E30-6C34-4FB8-8A50-3429770A2671</gtr:id><gtr:impact>More than 2000 views on YouTube</gtr:impact><gtr:outcomeId>58be851a0df089.12399765</gtr:outcomeId><gtr:title>Fly models of Parkinson's disease point way to new therapies</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://youtu.be/13oA5eiH-8s</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Published on Dec 28, 2016
doi.org/10.1242/bio.022186</gtr:description><gtr:id>F15379CD-5B10-4D82-B70D-5DC66B237D14</gtr:id><gtr:impact>More than 700 views on YouTube</gtr:impact><gtr:outcomeId>58be84bee57497.21792170</gtr:outcomeId><gtr:title>Niacin is neuroprotective in a fly model of Parkinson's disease</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://youtu.be/1e4oWI50IWg</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Published on Feb 6, 2017
http://dx.doi.org/10.1038/cdd.2016.158</gtr:description><gtr:id>7D99F781-6B29-4C16-97C7-6661E1DFD90F</gtr:id><gtr:impact>Exceeds 500 views on YouTube</gtr:impact><gtr:outcomeId>58be84213b0b06.78018380</gtr:outcomeId><gtr:title>Controlling genes to reverse the symptoms of Parkinson's disease</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://youtu.be/cFJJm2YZKKM</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Nick Wood</gtr:description><gtr:id>FA53FF46-6B88-4D93-B74A-C1A9F1C9B2B8</gtr:id><gtr:impact>17906618 19023330</gtr:impact><gtr:outcomeId>C98BC984635-1</gtr:outcomeId><gtr:partnerContribution>Access to data and significant intellectual input into your collaborator/partners research.</gtr:partnerContribution><gtr:piContribution>Access to data and significant intellectual input into collaborator/partners research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Pancreatic cancer UK Grant</gtr:description><gtr:id>052C7F11-D9EE-438C-AA2C-3F0357842575</gtr:id><gtr:impact>Funding for this research project</gtr:impact><gtr:outcomeId>dDneCyAgcYP-1</gtr:outcomeId><gtr:partnerContribution>Co-writers of the research proposal</gtr:partnerContribution><gtr:piContribution>Generated pilot data and outlined research proposal</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>WorldSkills Europe</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>EUROSKILLS - Leonardo da Vinci</gtr:description><gtr:id>E9D680A0-20AD-465A-A61F-247C9691E284</gtr:id><gtr:impact>Competence is Next Generation Sequencing technology for the trainees.</gtr:impact><gtr:outcomeId>YLXonjYCRN3-1</gtr:outcomeId><gtr:partnerContribution>Provided trainees</gtr:partnerContribution><gtr:piContribution>1. Development of skills in semi-quantitative PCR assays
2. Development of skills in quantitative PCR (qPCR) assays
3. Establishment of an assay for the detection of somatic mutations in formalin-fixed, paraffin- embedded (FFPE) cancer tissues, employing the Ion AmpliSeq Comprehensive Cancer Panel and Ion Torrent Semi-Conductor-based sequencing. This involves ultra-high multiplex PCR combined with targeted sequencing library construction for full exon coverage of 409 genes encompassing over 50% of the Wellcome Trust Sanger Institute Cancer Gene Census
4. Development of an assay for the qPCR validation of single-nucleotide variants (SNVs) detected by Ion Torrent sequencing</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Synta Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Synta ENCHANT Trial (9090-11)</gtr:description><gtr:id>D8E9343B-72B6-46B8-B3A0-95F34AA31DB5</gtr:id><gtr:impact>VCF files</gtr:impact><gtr:outcomeId>DpqB7BxhSBw-1</gtr:outcomeId><gtr:partnerContribution>Designed clinical trial and collected samples</gtr:partnerContribution><gtr:piContribution>Next generation sequencing of DNA from cancer patients</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Naples</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>LLP-ERASMUS</gtr:description><gtr:id>E750E028-BC94-4EBF-9B5B-A7ACCF9F0384</gtr:id><gtr:impact>xx</gtr:impact><gtr:outcomeId>bFYQdmpZGiL-1</gtr:outcomeId><gtr:partnerContribution>Contribute to research conducted in our laboratory</gtr:partnerContribution><gtr:piContribution>Hosting and training European Students</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Synta Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Synta GALAXY Trial</gtr:description><gtr:id>DEAFF486-4805-4C51-AF82-0708FDF498EF</gtr:id><gtr:impact>VCF files</gtr:impact><gtr:outcomeId>H7fBVc3e9QP-1</gtr:outcomeId><gtr:partnerContribution>Designed clinical trial and obtained samples</gtr:partnerContribution><gtr:piContribution>Next generation sequencing of DNA from cancer patients</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HOPE Grant (Pancreatic cancer)</gtr:description><gtr:id>99157BD3-A7C9-4A53-9383-C7A510099200</gtr:id><gtr:impact>Funding for this research proposal</gtr:impact><gtr:outcomeId>YmYFqLS48nG-1</gtr:outcomeId><gtr:partnerContribution>Co-writers of the research proposal</gtr:partnerContribution><gtr:piContribution>Outline the research proposal and generated pilot data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Roy Castle Grant</gtr:description><gtr:id>85116D0A-7270-464A-BD24-AA80CBF914AD</gtr:id><gtr:impact>Grant award from the Roy Castle Lung Cancer Foundation (http://www.roycastle.org)</gtr:impact><gtr:outcomeId>oak9jgxWpH2-1</gtr:outcomeId><gtr:partnerContribution>Insolation of cfDNA from human plasma</gtr:partnerContribution><gtr:piContribution>Molecular profiling of cancer genes present in circulating free DNA (cfDNA) of lung cancer patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>An article in the &quot;research highlights&quot; section of Nature Chemical Biology</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>237D6C8C-4453-4AFF-9814-7AFBCBE12CFB</gtr:id><gtr:impact>Dissemination of our work</gtr:impact><gtr:outcomeId>544a748a95c146.81641280</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.nature.com/nchembio/journal/v10/n3/full/nchembio.1469.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Presentation</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7C569C23-0FDE-4231-8C35-2788DE55CA71</gtr:id><gtr:impact>Sparked questions and discussions afterwards

School pupils asked for lab visits</gtr:impact><gtr:outcomeId>Co96ytqKT7p</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in the Science section of P?blico</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EAEC1483-C5CC-44E7-9DAC-9BE8F0CE9BEB</gtr:id><gtr:impact>Many direct enquiries about the therapeutic implications of our work

Direct enquiries</gtr:impact><gtr:outcomeId>544a7329d50e60.99109928</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.publico.pt/ciencia/noticia/uma-dieta-rica-em-acido-folico-podera-prevenir-ou-retardar-a-doenca-de-parkinson-1620115</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Study gives Parkinson's cure hope</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3725F34D-A9F8-45AB-A27F-FC1BBBC8BBC3</gtr:id><gtr:impact>http://news.bbc.co.uk/1/hi/england/leicestershire/7023096.stm

Increased awareness of research into the mechanisms of Parkinson's disease</gtr:impact><gtr:outcomeId>F29F863140E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://news.bbc.co.uk/1/hi/england/leicestershire/7023096.stm</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in BioWorld by Sharon Kingman. This focuses on our recent work focusing on nucleotide metabolism.</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5ABE7C60-9899-434D-93A4-0E39AA636EE0</gtr:id><gtr:impact>Increase awareness of our work

ds</gtr:impact><gtr:outcomeId>544a7406cb1b99.80183615</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bioworld.com/content/nucleotide-metabolism-key-parkinson's-disease-study-shows</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EMRSN Researchers Meeting 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>548B70F6-8E0F-445F-A262-7730FAEFA2D9</gtr:id><gtr:impact>A meeting of Parkinson's researches with members of the Parkinson's East Midlands Research Support Network, including those patients with Parkinson's disease. This includes science seminars, visits to the labs and an informal lunch.</gtr:impact><gtr:outcomeId>56cb1eabe29176.54981004</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview by ITV Central</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F42310AF-D46F-4F1D-81DD-FE8AC9060920</gtr:id><gtr:impact>Increased awareness of our research</gtr:impact><gtr:outcomeId>544a7506250b79.02141848</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.itv.com/news/central/story/2014-02-04/parkinsons-disease-big-breakthrough/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>DNA plasmids used in our publications are available through addgene.org</gtr:description><gtr:grantRef>MC_U132674518</gtr:grantRef><gtr:id>2CF35256-183C-4C88-82A2-117A1EB0F896</gtr:id><gtr:impact>Total number of distributed plasmids to date: 119</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>186E4698E07</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Addgene</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Transcription profiling by array of Drosophila melanogaster park25 (parkin) and pink1 (Pink1) mutants to identify neuron-specific transcriptional changes that may be relevant to Parkinson's disease</gtr:description><gtr:id>11DC0103-FABF-4CE8-9025-27665644B14D</gtr:id><gtr:impact>Stats: 80 views, 2 downloads</gtr:impact><gtr:outcomeId>58be7b49b470c7.44632867</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>E-MTAB-1406</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Cancer Diagnostics</gtr:companyName><gtr:description>We are now offering a diagnostic test for cancer, which profiles the DNA of the cancer. This test is available to selected oncologists and pharmaceutical companies.</gtr:description><gtr:id>CE16EC9B-8DC9-453D-B423-CEEC2CDE55E3</gtr:id><gtr:impact>Development of new blood-based cancer diagnostic tools</gtr:impact><gtr:outcomeId>DRnQVne5WzB</gtr:outcomeId><gtr:url>http://cancerdiagnostics.org</gtr:url><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>BF6F5C63-22B1-488E-AEA9-168B94E4151E</gtr:id><gtr:title>MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d453330a18b3c2fa924aa2105e1b7e2e"><gtr:id>d453330a18b3c2fa924aa2105e1b7e2e</gtr:id><gtr:otherNames>Lam D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>72CC1B96289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3036507-9243-4AE1-8357-C376F6F8582D</gtr:id><gtr:title>The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1a768ac0348b89871dc88cb7217499f"><gtr:id>d1a768ac0348b89871dc88cb7217499f</gtr:id><gtr:otherNames>Plun-Favreau H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>F7650D89B46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32830243-DA20-4A4B-B87E-A77A0F1CDB31</gtr:id><gtr:title>Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5524316ee915650b7810cd5a8485466"><gtr:id>b5524316ee915650b7810cd5a8485466</gtr:id><gtr:otherNames>Zhu JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12591_21_24386261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2337014E-E96E-41E4-85BC-A15EFC9609A7</gtr:id><gtr:title>Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due tomutations.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5a72f99f6e08e3.86039839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72FE5BC8-FBCF-422A-BB43-0B44FED3DEC0</gtr:id><gtr:title>PINK1 cleavage at position A103 by the mitochondrial protease PARL.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/948b5c491080c769d4906f5e34a78056"><gtr:id>948b5c491080c769d4906f5e34a78056</gtr:id><gtr:otherNames>Deas E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12591_21_21138942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF341927-A9BC-4EA4-BA18-82D769B6B62C</gtr:id><gtr:title>Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3edc2144895ea1217098953b44b7e7f"><gtr:id>e3edc2144895ea1217098953b44b7e7f</gtr:id><gtr:otherNames>Moisoi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>pm_12591_21_24161480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B849E9-65EB-4598-B5E4-1883E8CF5C3E</gtr:id><gtr:title>Drosophila ref(2)P is required for the parkin-mediated suppression of mitochondrial dysfunction in pink1 mutants.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ebf20c21b68cae6e37f1fa715136cbc"><gtr:id>6ebf20c21b68cae6e37f1fa715136cbc</gtr:id><gtr:otherNames>de Castro IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12591_21_24157867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82C18AA2-C41F-44AD-AD69-F942145B4B6E</gtr:id><gtr:title>MAP4K3 enhances the expression of the BH3-only protein BID.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d453330a18b3c2fa924aa2105e1b7e2e"><gtr:id>d453330a18b3c2fa924aa2105e1b7e2e</gtr:id><gtr:otherNames>Lam D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>FF79756C188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A4AC566-B416-427F-BF60-BADEF190C102</gtr:id><gtr:title>BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0aead0ddf2ae97c476aea7c3fb6ad116"><gtr:id>0aead0ddf2ae97c476aea7c3fb6ad116</gtr:id><gtr:otherNames>Andree M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12591_21_25056906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85D6BF91-702E-443A-A02D-F5CA2D4E50E6</gtr:id><gtr:title>dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd5d10f841c27e2f13c2b8f63b6c177"><gtr:id>2cd5d10f841c27e2f13c2b8f63b6c177</gtr:id><gtr:otherNames>Celardo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58be7a42c84a25.93073899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97D8F1FF-5465-49FA-80CE-26960B1E7D6B</gtr:id><gtr:title>Enhancing NADsalvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Biology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031280fa39e011bcf36429127e64c2c3"><gtr:id>031280fa39e011bcf36429127e64c2c3</gtr:id><gtr:otherNames>Lehmann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-6390</gtr:issn><gtr:outcomeId>5899d98312eee0.94975954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95F2A951-9208-425A-B3D8-F67F1E0578F8</gtr:id><gtr:title>Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b8f6322b88726fc82ca517e13207e22"><gtr:id>3b8f6322b88726fc82ca517e13207e22</gtr:id><gtr:otherNames>Burbulla LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>pm_12591_21_24743735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F8FFB6A-55AD-41B1-AE3A-35793145ECC7</gtr:id><gtr:title>Molecular motion regulates the activity of the Mitochondrial Serine Protease HtrA2.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74ffeb060ce9b835c351fa46634e5657"><gtr:id>74ffeb060ce9b835c351fa46634e5657</gtr:id><gtr:otherNames>Merski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72f9612f8ab5.15934400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C6AC2AA-3758-414A-8FFE-C7436F4CB74D</gtr:id><gtr:title>Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3edc2144895ea1217098953b44b7e7f"><gtr:id>e3edc2144895ea1217098953b44b7e7f</gtr:id><gtr:otherNames>Moisoi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>00CAEDFA93A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F8F48D3-2B1D-4826-8B32-908FBFC6B724</gtr:id><gtr:title>A yeast model of the Parkinson's disease-associated protein Parkin.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8e031d0aeaef9dfc973c5fb0337acfa"><gtr:id>d8e031d0aeaef9dfc973c5fb0337acfa</gtr:id><gtr:otherNames>Pereira C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>5899d982905403.27731352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11D0D5BA-8F2D-444E-A7B7-0F1832FA50F4</gtr:id><gtr:title>Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1825a11096392cdb4a65efacbb12473"><gtr:id>b1825a11096392cdb4a65efacbb12473</gtr:id><gtr:otherNames>Fitzgerald JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a72f9246f4d80.86596996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26BC01AC-3358-404A-B824-D40792387DCA</gtr:id><gtr:title>Cancer and neurodegeneration: between the devil and the deep blue sea.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1a768ac0348b89871dc88cb7217499f"><gtr:id>d1a768ac0348b89871dc88cb7217499f</gtr:id><gtr:otherNames>Plun-Favreau H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>iR2muatSmwf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6134CE39-E9A0-4B3C-B226-410246D2377D</gtr:id><gtr:title>Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8aabebb2da87ea465161268f62325f3"><gtr:id>e8aabebb2da87ea465161268f62325f3</gtr:id><gtr:otherNames>Pimenta de Castro I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12591_21_22301916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B5964FD-F2B5-4B9E-9C55-29FAC62312C4</gtr:id><gtr:title>Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98aa3c44c3ca01e1e78be4affdd39450"><gtr:id>98aa3c44c3ca01e1e78be4affdd39450</gtr:id><gtr:otherNames>Hall CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72fa72da71d6.84497568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD061EDA-928E-40DE-A1F9-F7DD347FF809</gtr:id><gtr:title>Mitochondrial Stress Signalling: HTRA2 and Parkinson's Disease.</gtr:title><gtr:parentPublicationTitle>International journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39159fa3c5fcbdbcf789383444c0b038"><gtr:id>39159fa3c5fcbdbcf789383444c0b038</gtr:id><gtr:otherNames>Desideri E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1687-8876</gtr:issn><gtr:outcomeId>pm_12591_21_22675361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78EBB628-8ABC-4BF0-A859-49A2241F1CC4</gtr:id><gtr:title>COUPLING BRAIN ENERGETICS WITH ANTIOXIDANT DEFENSE: METABOLIC RE-PROGRAMMING IN NEURONS BY PINK1 LOSS OF FUNCTION</gtr:title><gtr:parentPublicationTitle>ACTA PHYSIOLOGICA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae3c8e72b799b2ba21b51d86a4e2a968"><gtr:id>ae3c8e72b799b2ba21b51d86a4e2a968</gtr:id><gtr:otherNames>Requejo-Aguilar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b4ff639bae4.11741386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62777658-C625-48EF-B4A2-FF3625F522B9</gtr:id><gtr:title>Folinic acid is neuroprotective in a fly model of Parkinson's disease associated with 
&lt;em>pink1&lt;/em> mutations</gtr:title><gtr:parentPublicationTitle>Matters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031280fa39e011bcf36429127e64c2c3"><gtr:id>031280fa39e011bcf36429127e64c2c3</gtr:id><gtr:otherNames>Lehmann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72fb08c453d6.54428280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>301173A1-5E5B-4449-9721-26710CD98C04</gtr:id><gtr:title>The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf7e57c59bbeb7563f7adb332e7b2145"><gtr:id>cf7e57c59bbeb7563f7adb332e7b2145</gtr:id><gtr:otherNames>Baksh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>E867874F653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5663FCFD-9E75-4D3E-A570-CA445895FB4C</gtr:id><gtr:title>LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8e031d0aeaef9dfc973c5fb0337acfa"><gtr:id>d8e031d0aeaef9dfc973c5fb0337acfa</gtr:id><gtr:otherNames>Pereira C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_12591_21_24576675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE204825-DF33-4806-891F-40A08E1720CD</gtr:id><gtr:title>PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae3c8e72b799b2ba21b51d86a4e2a968"><gtr:id>ae3c8e72b799b2ba21b51d86a4e2a968</gtr:id><gtr:otherNames>Requejo-Aguilar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_12591_21_25058378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EAADC05-00B7-4CCA-B250-AE3866F82631</gtr:id><gtr:title>Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a3e867de7728760312563e9e5aba3fd"><gtr:id>9a3e867de7728760312563e9e5aba3fd</gtr:id><gtr:otherNames>Costa AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12591_21_23328674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE9F8EBB-0906-4F18-8632-7C643576FA0E</gtr:id><gtr:title>Mitochondrial quality control and neurological disease: an emerging connection.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ebf20c21b68cae6e37f1fa715136cbc"><gtr:id>6ebf20c21b68cae6e37f1fa715136cbc</gtr:id><gtr:otherNames>de Castro IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>G9hv5dT2z61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>745D23C1-9E89-4C9D-9729-2E633340BBD6</gtr:id><gtr:title>Insights into mitochondrial quality control pathways and Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031280fa39e011bcf36429127e64c2c3"><gtr:id>031280fa39e011bcf36429127e64c2c3</gtr:id><gtr:otherNames>Lehmann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn><gtr:outcomeId>pm_12591_21_23644494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1BBE046-4122-4DEA-9B29-41C219644958</gtr:id><gtr:title>Unravelling mitochondrial pathways to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd5d10f841c27e2f13c2b8f63b6c177"><gtr:id>2cd5d10f841c27e2f13c2b8f63b6c177</gtr:id><gtr:otherNames>Celardo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_12591_21_24117181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB7F920-255B-41E2-9ED8-EDA6517CD0FE</gtr:id><gtr:title>Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7d03d99f124c39fc9b975834d7cf6a7"><gtr:id>b7d03d99f124c39fc9b975834d7cf6a7</gtr:id><gtr:otherNames>Gerhardt E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12591_21_22205977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D2A300-0379-44F3-935D-E9003EADBD6B</gtr:id><gtr:title>Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54515a3c8ed1b31a9355cf483d04656a"><gtr:id>54515a3c8ed1b31a9355cf483d04656a</gtr:id><gtr:otherNames>Bartesaghi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54b92bffdbb5c9.43991055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BACD435-6BC0-44E1-9098-E9E9072BFD60</gtr:id><gtr:title>Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/713c94ab451482607a0f5b1c81261313"><gtr:id>713c94ab451482607a0f5b1c81261313</gtr:id><gtr:otherNames>Adamo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5a72f8df7a5185.04547253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3435AE-D484-4378-8A20-823120D6222A</gtr:id><gtr:title>Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c24855ecb6f14958c378c4a4b3352d2f"><gtr:id>c24855ecb6f14958c378c4a4b3352d2f</gtr:id><gtr:otherNames>Tufi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_12591_21_24441527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B7555F9-73FE-4071-B95F-EE5904660CA3</gtr:id><gtr:title>Paraquat-induced metabolic stress signature in human foetal mesencephalic cells</gtr:title><gtr:parentPublicationTitle>Matters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e470f6dfdb079908bd2a4ae3198a6d2"><gtr:id>1e470f6dfdb079908bd2a4ae3198a6d2</gtr:id><gtr:otherNames>Martins L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5899d9d18eed41.69390552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7547351-1943-4009-A4F6-28979B917022</gtr:id><gtr:title>Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd5d10f841c27e2f13c2b8f63b6c177"><gtr:id>2cd5d10f841c27e2f13c2b8f63b6c177</gtr:id><gtr:otherNames>Celardo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5899d982dc5559.93080705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4A02136-11D0-4059-87E4-77921FF07EE7</gtr:id><gtr:title>Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031280fa39e011bcf36429127e64c2c3"><gtr:id>031280fa39e011bcf36429127e64c2c3</gtr:id><gtr:otherNames>Lehmann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5899d982b477b7.78499885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BB32407-0BD0-4345-BC29-62DD87EE6A2B</gtr:id><gtr:title>Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a2b774c67d66392eed393dc1d0f373"><gtr:id>70a2b774c67d66392eed393dc1d0f373</gtr:id><gtr:otherNames>Kawamoto Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>74139C6DC1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF66E749-EF91-4213-83EE-5BE8237E3A85</gtr:id><gtr:title>Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e306c132ae005d5f09535048889ab5ee"><gtr:id>e306c132ae005d5f09535048889ab5ee</gtr:id><gtr:otherNames>Strauss KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>3B26B4AC87F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4959A298-42D6-4E02-8C0F-B9DF2A689CEF</gtr:id><gtr:title>Mitochondrial quality control and Parkinson's disease: a pathway unfolds.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ebf20c21b68cae6e37f1fa715136cbc"><gtr:id>6ebf20c21b68cae6e37f1fa715136cbc</gtr:id><gtr:otherNames>de Castro IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>aAB47GiuWfE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8F3226-DDA2-4285-9604-4D5C8995ABED</gtr:id><gtr:title>Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1825a11096392cdb4a65efacbb12473"><gtr:id>b1825a11096392cdb4a65efacbb12473</gtr:id><gtr:otherNames>Fitzgerald JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12591_21_21701498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE31C94-F3F3-48CE-9069-71C2AA896533</gtr:id><gtr:title>Peptide nucleic acid clamping to improve the sensitivity of Ion Torrent-based detection of an oncogenic mutation in 
&lt;em>KRAS&lt;/em></gtr:title><gtr:parentPublicationTitle>Matters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9328530985da6857a3518a831cc17b9"><gtr:id>d9328530985da6857a3518a831cc17b9</gtr:id><gtr:otherNames>Rakhit C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72fa1b860ec6.14696915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD09E1A7-2970-4306-87A3-D05541E46716</gtr:id><gtr:title>Therapeutic targets in cancer cell metabolism and death.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb8a7990e217f9ca736c2cd2a5d7c8a1"><gtr:id>eb8a7990e217f9ca736c2cd2a5d7c8a1</gtr:id><gtr:otherNames>Iaccarino I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_12591_21_21212794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8453383-AC30-4C1D-81BF-4DDCB7183FED</gtr:id><gtr:title>Handbook of Proteolytic Enzymes</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50f5bcfe5ad128756d0236c659034b9e"><gtr:id>50f5bcfe5ad128756d0236c659034b9e</gtr:id><gtr:otherNames>Weber N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>9780123822192</gtr:isbn><gtr:outcomeId>doi_12591__2_00569_X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C1B4BC5-5096-4511-807E-B2DACB7B958C</gtr:id><gtr:title>Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4af53352591f43e62822b8dbd2da2227"><gtr:id>4af53352591f43e62822b8dbd2da2227</gtr:id><gtr:otherNames>Tain LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5AA2760DED7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35BD2BA-0A41-4566-87D6-F18DF2A27424</gtr:id><gtr:title>Drosophila happyhour modulates JNK-dependent apoptosis.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d453330a18b3c2fa924aa2105e1b7e2e"><gtr:id>d453330a18b3c2fa924aa2105e1b7e2e</gtr:id><gtr:otherNames>Lam D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>ZAQSUzXPCHB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U132674518</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>